Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Oelke

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Discovery Medicine|August 14, 2010
Immunotherapy with enhanced self immune cellsMathias Oelke, Jonathan Schneck
Clinical Immunology (Orlando, Fla.)|March 30, 2004
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagementMathias Oelke, Jonathan P Schneck
Immunologic Research|January 21, 2010
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansionMathias Oelke, Jonathan P Schneck
Trends in Molecular Medicine|May 4, 2004
Quality and quantity: new strategies to improve immunotherapy of cancerChristine Krueger, Jonathan P Schneck, Mathias Oelke
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
Technological advances in adoptive immunotherapyMathias Oelke, Christine Krueger, Jonathan P Schneck
Journal of Visualized Experiments : Jove|April 21, 2011
HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTLYen-Ling Chiu, Jonathan P Schneck, Mathias Oelke
Transfusion|October 26, 2007
Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cellsAnanta Paine, Mathias Oelke, Rainer Blasczyk, et al.
Journal of Visualized Experiments : Jove|August 23, 2014
Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cellsChristian Schütz, Martin Fleck, Jonathan P Schneck, et al.
Rambam Maimonides Medical Journal|February 27, 2015
Adoptive T cell immunotherapy for cancerKarlo Perica, Juan Carlos Varela, Mathias Oelke, et al.
Trends in Molecular Medicine|August 17, 2005
Artificial antigen-presenting cells: artificial solutions for real diseasesMathias Oelke, Christine Krueger, Robert L Giuntoli, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Discovery Medicine|August 14, 2010
Immunotherapy with enhanced self immune cellsMathias Oelke, Jonathan Schneck
Clinical Immunology (Orlando, Fla.)|March 30, 2004
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagementMathias Oelke, Jonathan P Schneck
Immunologic Research|January 21, 2010
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansionMathias Oelke, Jonathan P Schneck
Trends in Molecular Medicine|May 4, 2004
Quality and quantity: new strategies to improve immunotherapy of cancerChristine Krueger, Jonathan P Schneck, Mathias Oelke
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
Technological advances in adoptive immunotherapyMathias Oelke, Christine Krueger, Jonathan P Schneck
Journal of Visualized Experiments : Jove|April 21, 2011
HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTLYen-Ling Chiu, Jonathan P Schneck, Mathias Oelke
Transfusion|October 26, 2007
Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cellsAnanta Paine, Mathias Oelke, Rainer Blasczyk, et al.
Journal of Visualized Experiments : Jove|August 23, 2014
Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cellsChristian Schütz, Martin Fleck, Jonathan P Schneck, et al.
Rambam Maimonides Medical Journal|February 27, 2015
Adoptive T cell immunotherapy for cancerKarlo Perica, Juan Carlos Varela, Mathias Oelke, et al.
Trends in Molecular Medicine|August 17, 2005
Artificial antigen-presenting cells: artificial solutions for real diseasesMathias Oelke, Christine Krueger, Robert L Giuntoli, et al.
Pageof 5